139 related articles for article (PubMed ID: 11051280)
21. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
[TBL] [Abstract][Full Text] [Related]
22. IL-12-independent LIGHT signaling enhances MHC class II disparate CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease.
Brown GR; Lee EL; El-Hayek J; Kintner K; Luck C
J Immunol; 2005 Apr; 174(8):4688-95. PubMed ID: 15814693
[TBL] [Abstract][Full Text] [Related]
23. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
[TBL] [Abstract][Full Text] [Related]
24. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.
Hill GR; Teshima T; Rebel VI; Krijanovski OI; Cooke KR; Brinson YS; Ferrara JL
J Immunol; 2000 Jan; 164(2):656-63. PubMed ID: 10623807
[TBL] [Abstract][Full Text] [Related]
25. Depletion of natural killer cells from the graft reduces interferon-gamma levels and lipopolysaccharide-induced tumor necrosis factor-alpha release in F1 hybrid mice with acute graft-versus-host disease.
Ellison CA; HayGlass KT; Fischer JM; Rector ES; MacDonald GC; Gartner JG
Transplantation; 1998 Aug; 66(3):284-94. PubMed ID: 9721794
[TBL] [Abstract][Full Text] [Related]
26. Graft-versus-host disease and graft-versus-leukemia effect in mice grafted with peripheral newborn blood.
de La Selle V; Gluckman E; Bruley-Rosset M
Blood; 1998 Nov; 92(10):3968-75. PubMed ID: 9808591
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of MHC class I-stimulated alloresponses by TNF/TNF receptor (TNFR)1 interactions and of MHC class II-stimulated alloresponses by TNF/TNFR2 interactions.
Brown GR; Thiele DL
Eur J Immunol; 2000 Oct; 30(10):2900-7. PubMed ID: 11069072
[TBL] [Abstract][Full Text] [Related]
28. In vitro characterization of a murine recipient anti-donor effector cell responsible for the development of chronic graft-versus-host disease.
Fast LD
J Immunol; 1991 Sep; 147(6):1731-8. PubMed ID: 1909729
[TBL] [Abstract][Full Text] [Related]
29. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease.
Kataoka Y; Iwasaki T; Kuroiwa T; Seto Y; Iwata N; Hashimoto N; Ogata A; Hamano T; Kakishita E
Immunology; 2001 Jul; 103(3):310-8. PubMed ID: 11454060
[TBL] [Abstract][Full Text] [Related]
30. Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function.
Leigh ND; O'Neill RE; Du W; Chen C; Qiu J; Ashwell JD; McCarthy PL; Chen GL; Cao X
J Immunol; 2017 Jul; 199(1):336-347. PubMed ID: 28550198
[TBL] [Abstract][Full Text] [Related]
31. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
32. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
[TBL] [Abstract][Full Text] [Related]
33. The nephritogenic T cell response in murine chronic graft-versus-host disease.
Meyers CM; Tomaszewski JE; Glass JD; Chen CW
J Immunol; 1998 Nov; 161(10):5321-30. PubMed ID: 9820505
[TBL] [Abstract][Full Text] [Related]
34. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
[TBL] [Abstract][Full Text] [Related]
35. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
Rus V; Svetic A; Nguyen P; Gause WC; Via CS
J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
[TBL] [Abstract][Full Text] [Related]
37. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.
Aranda R; Sydora BC; McAllister PL; Binder SW; Yang HY; Targan SR; Kronenberg M
J Immunol; 1997 Apr; 158(7):3464-73. PubMed ID: 9120308
[TBL] [Abstract][Full Text] [Related]
38. Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease.
Zhao D; Young JS; Chen YH; Shen E; Yi T; Todorov I; Chu PG; Forman SJ; Zeng D
J Immunol; 2011 Jan; 186(2):856-68. PubMed ID: 21149609
[TBL] [Abstract][Full Text] [Related]
39. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
[TBL] [Abstract][Full Text] [Related]
40. Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells.
Liu J; Heuer JG; Na S; Galbreath E; Zhang T; Yang DD; Glasebrook A; Song HY
J Immunol; 2002 Oct; 169(7):3993-8. PubMed ID: 12244201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]